ConductScience.org, home

Paper42985552PubMed

Urine sediment (uSed) in molecular diagnosis of genitourinary cancer: From materials to methods.

Zhao J and 1 other. J Liq Biopsy, 2026.

Cite this record

ConductScience Library. Urine sediment (uSed) in molecular diagnosis of genitourinary cancer: From materials to methods. Papers, record 42985552. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42985552

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Urine sediment (uSed) in molecular diagnosis of genitourinary cancer: From materials to methods.
Journal
J Liq Biopsy
Year
2026
Publication types
Journal Article, Review
Revised in PubMed
2026-11-06

Source PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhao JJinming
2Song XXingguo

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References121

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19176487Detection of bladder cancer recurrence by microsatellite analysis of urine.Nat Med1997https://conductscience.org/library/papers/9176487PubMed
229672570Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer.PLoS One2018https://conductscience.org/library/papers/29672570PubMed
316328066Genomic instability analysis of urine sediment versus tumor tissue in transitional cell carcinoma of the urinary bladder.Oncol Rep2006https://conductscience.org/library/papers/16328066PubMed
430654976Measurement of Urinary Level of a Specific Competing endogenous RNA network (FOS and RCAN mRNA/ miR-324-5p, miR-4738-3p, /lncRNA miR-497-HG) Enables Diagnosis of Bladder Cancer.Urol Oncol2019https://conductscience.org/library/papers/30654976PubMed
516697794Multiplex polymerase chain reaction for microsatellite analysis of urine sediment cells: a rapid and inexpensive method for diagnosing and monitoring superficial transitional bladder cell carcinoma.J Urol2006https://conductscience.org/library/papers/16697794PubMed
639284767Effects of preanalytical sample collection and handling on comprehensive metabolite measurements in human urine biospecimens.Am J Epidemiol2026https://conductscience.org/library/papers/39284767PubMed
741449174Prostate cancer diagnosis using sensitive and sophisticated machine learning classifiers based on non-invasive urinary RNA biomarkers (PCASSO).Sci Rep2025https://conductscience.org/library/papers/41449174PubMed
842108902Surface-enhanced Raman spectroscopy for comprehensive urinalysis: advances, challenges, and clinical perspectives.Analyst2026https://conductscience.org/library/papers/42108902PubMed
941038864Robustness of urinary extracellular vesicle-derived MiRNA profiles over multiple days and the impact of urine concentration.Sci Rep2025https://conductscience.org/library/papers/41038864PubMed
1037652824Preoperative urine sediment chromosomal instability level predicts urothelial cancer prognosis.Urol Oncol2023https://conductscience.org/library/papers/37652824PubMed
1137055445Urinary miR-16-5p can be used as a potential marker of endocapillary hypercellularity in IgA nephropathy.Sci Rep2023https://conductscience.org/library/papers/37055445PubMed
1235174071Investigating Urinary Circular RNA Biomarkers for Improved Detection of Renal Cell Carcinoma.Front Oncol2021https://conductscience.org/library/papers/35174071PubMed
1338572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
1415669002Renal and urinary proteomics: current applications and challenges.Proteomics2005https://conductscience.org/library/papers/15669002PubMed
1511751381Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features.Cancer Res2001https://conductscience.org/library/papers/11751381PubMed
1621144642A panel of TMPRSS2:ERG fusion transcript markers for urine-based prostate cancer detection with high specificity and sensitivity.Eur Urol2011https://conductscience.org/library/papers/21144642PubMed
1722879988Detection of bladder cancer using proteomic profiling of urine sediments.PLoS One2012https://conductscience.org/library/papers/22879988PubMed
1820875751Splicing variants of carbonic anhydrase IX in bladder cancer and urine sediments.Urol Oncol2012https://conductscience.org/library/papers/20875751PubMed
1936855829Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario.Technol Cancer Res Treat2023https://conductscience.org/library/papers/36855829PubMed
2037443032A three-snoRNA signature: SNORD15A, SNORD35B and SNORD60 as novel biomarker for renal cell carcinoma.Cancer Cell Int2023https://conductscience.org/library/papers/37443032PubMed

See all 121 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42985552

GET https://conductscience.org/api/papers/v1/42985552/references?page=2